Bioinformatics startup Proscia has announced that contract research organization (CRO) Virscio has chosen Concentriq for Research to provide faster and more informed drug safety insights.
Concentriq for Research is a digital platform designed by Proscia for image-based research in the field of pathology. This platform brings together various data and applications from multiple locations, streamlining pathology operations to discover insights that help the drug discovery and development process.
Virscio recognized that optimizing its pathology operations by adopting Concentriq for Research would enable its sponsors to more rapidly and confidently advance lead programs and get therapeutic breakthroughs to patients sooner. Concentriq will unify Virscio’s teams and data across Good Laboratory Practice (GLP) and non-regulated studies, streamline collaboration among scientists, sponsors, and external collaborators, and offer interoperability with leading AI applications.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.